Felix E; Jager, Agnes; Seynaeve, Caroline M; Van, Ngoc M; Foekens, John A; Martens, John W M; Sleijfer, Stefan.Neoplasia; 18(11): 647-653, 2016 Oct 17.14.Angiogenesis and Antiangiogenesis in Triple-Negative Breast cancer.Ribatti, Domenico; Nico, Beatrice; Ruggieri, Simona; Tamma, Roberto; Simone, Giovanni; Mangia, Anita.Transl Oncol; 9(5): 453-457, 2016 Oct.Artigo em ENG | MEDLINE | ID: mdl-2775135015.Expression of Programmed Death Receptor Ligand 1 with High Tumor-Infiltrating Lymphocytes Is Associated with Better Prognosis in Breast Cancer.Bae, Sang Byung; Cho, Hyun Deuk; Oh, Mee-Hye; Lee, Ji-Hye; Jang, Si-Hyong; Hong, Soon Auck; Cho, Junhun; Kim, Sung Yong; Han, Sun Wook; Lee, Jong Eun; Kim, Han Jo; Lee, Hyun Ju.J Breast Cancer; 19(3): 242-251, 2016 Sep.16.BCL2 as a Subtype-Specific Prognostic Marker for Breast Cancer.Eom, Yong Hwa; Kim, Hyung Suk; Lee, Ahwon; Song, Byung Joo; Chae, Byung Joo.J Breast Cancer; 19(3): 252-260, 2016 Sep.17.Patients with Concordant Triple-Negative Phenotype between Primary Breast Cancers and Corresponding Metastases Have Poor Prognosis.Shin, Hee-Chul; Han, Wonshik; Moon, Hyeong-Gon; Park, In-Ae; Noh, Dong-Young.J Breast Cancer; 19(3): 268-274, 2016 Sep.18.Low Ki67/high ATM protein expression in malignant tumors predicts favorable prognosis in a retrospective study of early stage hormone receptor positive breast cancer.Feng, Xiaolan; Li, Haocheng; Kornaga, Elizabeth N; Dean, Michelle; Lees-Miller, Susan P; Riabowol, Karl; Magliocco, Anthony M; Morris, Don; Watson, Peter H; Enwere, Emeka K; Bebb, Gwyn; Paterson, Alexander.Oncotarget; 2016 Oct 12.19.Breast Cancer Survival Analysis Based on Immunohistochemistry Subtypes (ER/PR/HER2): a Retrospective Cohort Study.Poorolajal, Jalal; Nafissi, Nahid; Akbari, Mohammad Esmaeil; Mahjub, Hossein; Esmailnasab, Nader; Babaee, Ebrahim.Arch Iran Med; 19(10): 680-686, 2016 Oct.20.Prognostic and predictive value of tumor infiltrating lymphocytes in early breast cancer.Criscitiello, Carmen; Esposito, Angela; Trapani, Dario; Curigliano, Giuseppe.Cancer Treat Rev; 50: 205-207, 2016 Oct 6.21.Low expression of miR-409-3p is a prognostic marker for breast cancer.Cao, G-H; Sun, X-L; Wu, F; Chen, W-F; Li, J-Q; Hu, W-C.Eur Rev Med Pharmacol Sci; 20(18): 3825-3829, 2016 Sep.22.Human epidermal growth factor receptor 4 (HER4) is a favorable prognostic marker of breast cancer: a systematic review and meta-analysis.Wang, Jue; Yin, Jun; Yang, Qing; Ding, Feng; Chen, Xiao; Li, Bingjie; Tian, Xingsong.Oncotarget; 2016 Oct 5.23.Clinicopathological Significance of the Proliferation Markers Ki67, RacGAP1, and Topoisomerase 2 Alpha in Breast Cancer.Sahin, Sevinc; Isik Gonul, Ipek; Cakir, Asli; Seckin, Selda; Uluoglu, Omer.Int J Surg Pathol; 24(7): 607-13, 2016 Oct.24.1 Integrin as a Prognostic and Predictive Marker in Triple-Negative Breast Cancer.Yin, Hsin-Ling; Wu, Chun-Chieh; Lin, Chih-Hung; Chai, Chee-Yin; Hou, Ming-Feng; Chang, Shu-Jyuan; Tsai, Hung-Pei;Hung, Wen-Chun; Pan, Mei-Ren; Luo, Chi-Wen.Int J Mol Sci; 17(9)2016.25.Prognostic significance of androgen receptor expression in invasive breast cancer: transcriptomic and protein expression analysis.Aleskandarany, Mohammad A; Abduljabbar, Rezvan; Ashankyty, Ibraheem; Elmouna, Ahmed; Jerjees, Dena; Ali, Simak;Buluwela, Laki; Diez-Rodriguez, Maria; Caldas, Carlos; Green, Andrew R; Ellis, Ian O; Rakha, Emad A.Breast Cancer Res Treat; 159(2): 215-27, 2016 Sep.26.St Gallen 2015 subtyping of luminal breast cancers: impact of different Ki67-based proliferation assessment methods.Focke, Cornelia M; van Diest, Paul J; Decker, Thomas.Breast Cancer Res Treat; 159(2): 257-63, 2016 Sep.27.Validated biomarkers: The key to precision treatment in patients with breast cancer.Duffy, Michael J; O'Donovan, Norma; McDermott, Enda; Crown, John.Breast; 29: 192-201, 2016 Oct.28.Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of